WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Disc Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-12 10:34 am Sale | 2025-06-30 | 13G | Disc Medicine, Inc. IRON | WELLINGTON MANAGEMENT GROUP LLP | 1,432,090 4.100% | -911,409 (-38.89%) | Filing |
| 2025-05-12 10:44 am Purchase | 2025-03-31 | 13G | Disc Medicine, Inc. IRON | WELLINGTON MANAGEMENT GROUP LLP | 2,343,499 6.800% | 948,094 (+67.94%) | Filing |
| 2025-02-10 10:25 am Sale | 2024-12-31 | 13G | Disc Medicine, Inc. IRON | WELLINGTON MANAGEMENT GROUP LLP | 1,395,405 4.700% | -444,821 (-24.17%) | Filing |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | Disc Medicine, Inc. IRON | WELLINGTON MANAGEMENT GROUP LLP | 1,840,226 6.190% | 1,840,226 (New Position) | Filing |